TRACED: In vivo imaging of extracellular intrinsic diffusivity, tortuosity, cell size distribution and cell density in human glioma patients

📅 2026-05-04
📈 Citations: 0
Influential: 0
📄 PDF

career value

193K/year
🤖 AI Summary
Current diffusion MRI models struggle to accurately quantify the extracellular intrinsic diffusivity and microstructural parameters of tumors at intermediate time scales. This work proposes TRACED, a biophysical model that integrates Monte Carlo diffusion simulations based on spherical cell distributions with neural networks, and introduces Sim2PINN—a physics-informed transfer learning framework—to enable, for the first time, simultaneous in vivo quantification of extracellular intrinsic diffusivity, tortuosity, cell size distribution, and cellular density in glioma patients. Evaluated on eight patients with mixed-grade gliomas, TRACED significantly outperformed conventional two-compartment models and showed agreement with histological measurements in two cases, demonstrating its accuracy and generalizability.
📝 Abstract
The lack of analytical models describing diffusion time dependence at intermediate time scales in complex tissue microstructure limits the accurate quantification of extracellular diffusivity and tissue microstructure. We introduce TRACED, a biophysical model that incorporates diffusion time dependence in cell distributions to quantify pathologically-relevant properties in solid tumors. Neural networks were trained on Monte Carlo diffusion simulations using sphere distribution-based geometries to enable the rapid computation of time-dependent diffusion MRI signals in cell populations of variable cell size. Model sensitivity and fit performance were assessed via simulation. Diffusion data from eight mixed-grade glioma patients was fitted using the TRACED model. Data fitting was performed using a novel physics-informed transfer learning pipeline, Sim2PINN. In two patients, cell size measurements were compared directly with image-localized histology. Simulation results indicate improved parameter estimation compared to the simple two-compartment model. TRACED enabled the simultaneous in vivo quantification of intracellular volume fraction, cell size distribution, extracellular intrinsic diffusivity, and tortuosity in glioma patients. Neural network implementations of diffusion time-dependence and tortuosity showed behavior consistent with coarse-graining and effective medium theory, respectively. Future work will explore the clinical utility of TRACED parameters in additional patients.
Problem

Research questions and friction points this paper is trying to address.

diffusion time dependence
tissue microstructure
extracellular diffusivity
cell size distribution
glioma
Innovation

Methods, ideas, or system contributions that make the work stand out.

TRACED
diffusion time dependence
physics-informed neural networks
cell size distribution
tortuosity
J
Joshua K. Marchant
Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Boston, United States of America; Harvard-MIT Program in Health Sciences and Technology, Massachusetts Institute of Technology, Cambridge, United States of America
H
Hong-Hsi Lee
Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Boston, United States of America; Harvard Medical School, Boston, United States of America
E
Elizabeth R. Gerstner
Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Boston, United States of America; Department of Neurology, Massachusetts General Hospital, Boston, United States of America; Mass General Brigham Cancer Institute, Boston, United States of America
Susie Y. Huang
Susie Y. Huang
Massachusetts General Hospital, Athinoula A. Martinos Center for Biomedical Imaging
Magnetic resonance imagingneuroimagingdiffusion MRI
B
Bruce R. Rosen
Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Boston, United States of America; Harvard-MIT Program in Health Sciences and Technology, Massachusetts Institute of Technology, Cambridge, United States of America; Harvard Medical School, Boston, United States of America